LONDON, ROME and ZUG, Switzerland, Sept. 29, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN), today announced its wholly owned subsidiary, Nanomi B.V. ('Nanomi'), has signed a definitive agreement for the...
Hence then, the article about lupin strengthens its global specialty ophthalmology business with acquisition of visufarma from gho capital was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital )
Also on site :
- Most Australian teens admit the social media ban isn’t working as they try to sidestep age verification blocks with face masks and their parents’ IDs
- 1998 ‘Days of Our Lives’ Departure Ended a Record-Breaking Run of Six Distinct Roles That Changed Daytime TV Forever
- This Is the 'Fairy Godmother' Heat Protectant Spray That Hairstylists Swear By